tm logo
AITEM
Live/Registered
REGISTERED

on 30 Apr 2024

Last Applicant/ Owned by

NO. 658, BINAN ROAD, BINJIANG DISTRICT,HANGZHOU 310053 ZHEJIANG PROVINCE

CN

Serial Number

79350047 filed on 15th Jul 2022

Registration Number

7369448 registered on 30th Apr 2024

in the Principal Register

Correspondent Address

MARK E. BANDY

MARK E. BANDY Rankin Hill & Clark, LLP

Willoughby, OH 44094

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

AITEM

Design of computer databases; Conversion of computer programs and data, other than physical conversion; Digitization of documents being scanning; Computer programming in medical care; Providing virtual computer systems through cloud computing; Pharmaceutical drug development; Drug evaluation in the nature of evaluation and testing of illegal clandestine drug lab sites for the presence of hazardous Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Design of computer databases; Conversion of computer programs and data, other than physical conversion; Digitization of documents being scanning; Computer programming in medical care; Providing virtual computer systems through cloud computing; Pharmaceutical drug development; Drug evaluation in the nature of evaluation and testing of illegal clandestine drug lab sites for the presence of hazardous and illegal materials; Pharmaceutical research; Scientific research and development; Conducting early evaluation of new drug fields in the nature of evaluation and testing of illegal clandestine drug lab sites for the presence of hazardous and illegal materials; Computer hardware design; Research and development of new products for others; Providing computer software design for others; Electronic data storage; Conducting technical project studies in the nature of technical research in the field of pharmaceutical studies; Conversion of data or documents from physical to electronic media; Clinical trials, namely, scientific research in the nature of conducting clinical trials for others; Animal genetics research in the nature of studying the mechanism of action of compound combinations in animals; Computer programming


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Medicines for human purposes, namely, for use for central nervous system diseases, liver diseases, lung diseases, cancers, immune system diseases, infectious diseases, kidney and gastrointestinal diseases; Pharmaceutical preparations, namely, for use for central nervous system medications, liver disease medications, lung disease medications, anti-tumor medications, immune system medications, anti-infective medications, kidney disease medications, and gastrointestinal medications; Chemico-pharmaceutical preparations, namely, for use for central nervous system medications, liver disease medications, lung disease medications, anti-tumor medications, immune system medications, anti-infective medications, kidney disease medications, and gastrointestinal medications; Capsules being medicines, namely, capsules for the treatment of central nervous system diseases, liver diseases, lung diseases, cancers, immune system diseases, infectious diseases, kidney related diseases, gastrointestinal diseases; Sedatives; Vaccines; Drugs for medical purposes, namely, central nervous system medications, liver disease medications, lung disease medications, anti-tumor medications, immune system medications, anti-infective medications, kidney disease medications, and gastrointestinal medications; Medicines in tablet form, namely, medicinal preparations for the mouth to be applied in the form of tablets; Injectable medicinal solutions, namely, powder for injection, parenteral solutions, solutions for injection, intravenous injections, suspensions for injection, sterile powders for injection, intravenous injections, emulsion for injection, emulsion injections, powder injections, and concentrated solutions for injection, all for the treatment of central nervous system diseases, liver diseases, lung diseases, cancers, immune system diseases, infectious diseases, kidney and gastrointestinal diseases; Pain relief medication; Immunostimulants; Pharmaceuticals for the treatment of cancer; Pharmaceuticals for the treatment of infectious diseases; Pharmaceuticals for the treatment of viral diseases; Medicinal preparations for the treatment of musculoskeletal disorders; Drugs and preparations for the treatment of gastrointestinal diseases; Medicinal preparations for skin diseases


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79350047

Mark Type

No Service Mark

Attorney Docket Number

No LIU-54671

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
27th Oct 2024GENERIC MADRID TRANSACTION SENT TO IB
26th Oct 2024GENERIC MADRID TRANSACTION CREATED
30th Jul 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
30th Apr 2024REGISTERED-PRINCIPAL REGISTER
30th Apr 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
17th Mar 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
26th Feb 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
21st Feb 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
19th Feb 2024NOTIFICATION PROCESSED BY IB
13th Feb 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED